aXichem AB (FRA:A6X) Short Interest


FRA:A6X aXichem AB FRA:A6X
50 GF Score
Price €0.10
GF Value €0.22
View Full Analysis

What is aXichem AB Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:A6X vs LIN, SHW, ECL: Short Interest Comparison

For the Specialty Chemicals subindustry, aXichem AB's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

aXichem AB Short Interest vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, aXichem AB's Short Interest distribution charts can be found below:

* The bar in red indicates where aXichem AB's Short Interest falls into.


FRA:A6X
50GF Score
aXichem AB FRA:A6X
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is aXichem AB (FRA:A6X) Overvalued in 2026?

Based on GuruFocus' analysis, aXichem AB stock appears to be undervalued. The current stock price of €0.10 is trading 53.2% below its estimated GF Value™ of €0.22.

Key valuation signals for FRA:A6X:

  • Short Interest:
  • GF Value™: €0.22 vs. price of €0.10 (53.2% below fair value)
  • GF Score™: 50/100

No single metric tells the full story. See the FRA:A6X stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

aXichem AB Business Description

Other Exchanges AXIC A:Sweden
Address Sodergatan 26, Malmo, NOR, 211 34
aXichem AB develops, patents, markets and sells natural analogue industrial chemicals, which are synthetically produced substances with similar and comparable properties to natural substances. The Company's business concept is to develop, patent, market and sell natural analogue industrial chemicals. Its commercial focus is on the proprietary patented product phenylcapsaicin, the Company's first product, which is marketed under the registered trademarks aXiphen as an additive in animal feed and aXivite as an ingredient in food supplements and as a bioenhancer. The Company's product portfolio comprises Phenylcapsaicin, aXiphen, aXiphen bio, and aXivite. The Company's focus is on establishing aXiphen as an additive in poultry feed and pig feed.
50GF Score

Get the complete analysis for FRA:A6X

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.10
Price
€0.22
GF Value